151 related articles for article (PubMed ID: 38163426)
1. Searching for a "Window of Opportunity" in the Treatment of Vulvar Lichen Sclerosus: Evidence for Therapeutic Benefits of an Early Corticosteroid Treatment.
Borghi A; Flacco ME; Schettini N; Toni G; Corazza M
Dermatology; 2024; 240(2):195-204. PubMed ID: 38163426
[TBL] [Abstract][Full Text] [Related]
2. Does Clearance of Vulvar Lichen Sclerosus after a Corticosteroid Treatment Correspond to a Decrease in Disease-Related Burden? Results from a Cohort Study Using Pictorial Representation of Illness and Self-Measure and the Dermatology Life Quality Index.
Borghi A; Flacco ME; Zedde P; Toni G; Schettini N; Corazza M
Dermatology; 2023; 239(1):81-90. PubMed ID: 36382657
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and pathological analysis of 345 cases of vulvar lichen sclerosus and a preliminary study on the frequency of maintenance treatment].
Sun XY; Xiao YP; Sun YX; Zhang Q; Cong Q
Zhonghua Fu Chan Ke Za Zhi; 2024 Jan; 59(1):56-63. PubMed ID: 38228516
[No Abstract] [Full Text] [Related]
4. Clearance in vulvar lichen sclerosus: a realistic treatment endpoint or a chimera?
Borghi A; Virgili A; Minghetti S; Toni G; Corazza M
J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):96-101. PubMed ID: 28796915
[TBL] [Abstract][Full Text] [Related]
5. Does longer duration of corticosteroid treatment improve clearance in vulvar lichen sclerosus? Results from a single centre, comparative, open label study.
Corazza M; Toni G; Valpiani G; Morotti C; Borghi A
Dermatol Ther; 2021 Jul; 34(4):e14955. PubMed ID: 33835646
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for platelet rich plasma injection in vulvar lichen sclerosus? A self-controlled pilot study.
Boero V; Cetera GE; Caia C; Villa S; Montemurro T; Brambilla M; Monti E; Iorio M; Somigliana E; Vercellini P; Prati D
Arch Gynecol Obstet; 2024 Jun; 309(6):2719-2726. PubMed ID: 38523203
[TBL] [Abstract][Full Text] [Related]
7. Fractional CO
Stewart K; Javaid S; Schallen KP; Bartlett S; Carlson NA
Lasers Surg Med; 2022 Jan; 54(1):138-151. PubMed ID: 34541702
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of prescribing topical corticosteroids to patients with lichen sclerosus following surgery for vulvar cancer: a survey among gynaecologic oncologists in The Netherlands.
Voss FO; Groenewegen KL; Vermaat H; Bleeker MCG; van Beurden M
J Obstet Gynaecol; 2024 Dec; 44(1):2294330. PubMed ID: 38156715
[TBL] [Abstract][Full Text] [Related]
9. Advances in the pathogenesis of vulvar lichen sclerosus.
Xie X; Wu K
Mol Biol Rep; 2024 Mar; 51(1):396. PubMed ID: 38453810
[TBL] [Abstract][Full Text] [Related]
10. Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study.
Virgili A; Minghetti S; Borghi A; Corazza M
Br J Dermatol; 2013 Jun; 168(6):1316-24. PubMed ID: 23398459
[TBL] [Abstract][Full Text] [Related]
11. Measuring perceived benefit and disease-related burden in patients affected with vulvar lichen sclerosus after a standard topical corticosteroid treatment. Results from a cohort study using Pictorial Representation of Illness and Self-measure and Dermatology Life Quality Index.
Borghi A; Odorici G; Scuderi V; Valpiani G; Morotti C; Corazza M
Dermatol Ther; 2020 Nov; 33(6):e14334. PubMed ID: 32974986
[TBL] [Abstract][Full Text] [Related]
12. Topical Corticosteroid Phobia Among Women Affected With Vulvar Lichen Sclerosus: Results From a Cross-sectional Survey.
Borghi A; Flacco ME; Pacetti L; Toni G; Corazza M
J Low Genit Tract Dis; 2024 Apr; 28(2):169-174. PubMed ID: 38346422
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy analysis of 5-aminolevulinic acid photodynamic therapy for vulvar lichen sclerosus.
Qu Z; Lin X; Liu M; Wang J; Wang F; Zhang B; Shen L; Wang Z
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104035. PubMed ID: 38442799
[TBL] [Abstract][Full Text] [Related]
14. Vulvar Lichen Sclerosus: Navigating Sex Hormone Dynamics and Pioneering Personalized Treatment Paradigm.
Popa A; Dumitrascu MC; Petca A; Petca RC; Sandru F
J Pers Med; 2024 Jan; 14(1):. PubMed ID: 38248777
[TBL] [Abstract][Full Text] [Related]
15. Monitoring adherence to vulvar lichen sclerosus treatment - a prospective study.
Zaino ML; Pixley JN; Subramanian VM; Sirdeshmukh D; Feldman SR; Pichardo RO
J Dermatolog Treat; 2024 Dec; 35(1):2285725. PubMed ID: 38240095
[No Abstract] [Full Text] [Related]
16. Effects of Fractional CO
Filippini M; Sozzi J; Farinelli M; Verdelli A
Photobiomodul Photomed Laser Surg; 2021 Dec; 39(12):782-788. PubMed ID: 34878932
[No Abstract] [Full Text] [Related]
17. The efficacy of 5-aminolevulinic acid photodynamic therapy for pediatric vulvar lichen sclerosus.
Zhang S; Wang Y; Wang J; Liu J
Photodiagnosis Photodyn Ther; 2024 Feb; 45():103986. PubMed ID: 38272155
[TBL] [Abstract][Full Text] [Related]
18. Mometasone fuoroate 0.1% ointment in the treatment of vulvar lichen sclerosus: a study of efficacy and safety on a large cohort of patients.
Virgili A; Borghi A; Minghetti S; Corazza M
J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):943-8. PubMed ID: 23879234
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the therapeutic effects of Photodynamic Therapy in vulvar lichen sclerosus and impact on patient quality of life and sexual funtion.
Cao Y; Qu Z; Sun X; Cui G; Wei H; Wang Z; Lin X
Photodiagnosis Photodyn Ther; 2024 May; ():104226. PubMed ID: 38825158
[TBL] [Abstract][Full Text] [Related]
20. Clinical and dermoscopic changes of vulvar lichen sclerosus after topical corticosteroid treatment.
Borghi A; Corazza M; Minghetti S; Toni G; Virgili A
J Dermatol; 2016 Sep; 43(9):1078-82. PubMed ID: 27075682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
